Phase 1 study to evaluate safety and efficacy of ipilimumab + nivolumab + external beam radiotherapy in patients with metastatic melanoma. Background: We have previously shown that the IL-2 inducible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results